Literature DB >> 2467945

Molecular analysis of H-2-deficient lymphoma lines. Distinct defects in biosynthesis and association of MHC class I heavy chains and beta 2-microglobulin observed in cells with increased sensitivity to NK cell lysis.

H G Ljunggren1, S Pääbo, M Cochet, G Kling, P Kourilsky, K Kärre.   

Abstract

It has previously been reported that MHC class I-deficient RBL-5 and YAC-1 lymphoma sublines show an enhanced NK sensitivity in vitro. In the present study such lymphoma variants were found to have different defects in H-2 biosynthesis such as 1) reduced beta 2-microglobulin and H-2 H chain transcription, 2) block in beta 2-microglobulin translation, and 3) impaired association between beta 2-microglobulin and H-2 H chains. For lines with the latter two defects, the results suggested that a major part of the H chains were arrested before the middle Golgi complex as indicated by their failure to undergo carbohydrate side chain trimming. The data suggest that NK sensitivity can be directly influenced by the membrane expression of MHC class I gene products of tumor targets because three independent molecular defects, all interfering with the cell surface H-2 expression, gave rise to NK-sensitive phenotypes. These variant lines will also be useful tools for studies of H-2 glycoprotein assembly and transport and for Ag presentation to CTL.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2467945

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  27 in total

Review 1.  Role of major histocompatibility complex class-I molecules in tumor rejection. New insights from studies with synthetic peptides and transgenic mice.

Authors:  P Höglund; H G Ljunggren; K Kärre; G Jay
Journal:  Immunol Res       Date:  1990       Impact factor: 2.829

2.  Class I-induced resistance to natural killing: identification of nonpermissive residues in HLA-A2.

Authors:  W J Storkus; R D Salter; J Alexander; F E Ward; R E Ruiz; P Cresswell; J R Dawson
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-15       Impact factor: 11.205

3.  Low temperature and peptides favor the formation of class I heterodimers on RMA-S cells at the cell surface.

Authors:  K L Rock; C Gramm; B Benacerraf
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-15       Impact factor: 11.205

Review 4.  Interleukin-10: a cytokine used by tumors to escape immunosurveillance.

Authors:  F Salazar-Onfray
Journal:  Med Oncol       Date:  1999-07       Impact factor: 3.064

5.  Single-residue changes in class I major histocompatibility complex molecules stimulate responses to self peptides.

Authors:  A G Grandea; M J Bevan
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

Review 6.  Co-receptors and recognition of self at the immunological synapse.

Authors:  Nicholas R J Gascoigne; Tomasz Zal; Pia P Yachi; John A H Hoerter
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

7.  Defective presentation of endogenous antigens by a murine sarcoma. Implications for the failure of an anti-tumor immune response.

Authors:  N P Restifo; F Esquivel; A L Asher; H Stötter; R J Barth; J R Bennink; J J Mulé; J W Yewdell; S A Rosenberg
Journal:  J Immunol       Date:  1991-08-15       Impact factor: 5.422

8.  Abnormal class I assembly and peptide presentation in the nonobese diabetic mouse.

Authors:  F Li; J Guo; Y Fu; G Yan; D Faustman
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-08       Impact factor: 11.205

9.  Altered natural killer cell repertoire in Tap-1 mutant mice.

Authors:  H G Ljunggren; L Van Kaer; H L Ploegh; S Tonegawa
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-05       Impact factor: 11.205

10.  Multipotent adult germ-line stem cells, like other pluripotent stem cells, can be killed by cytotoxic T lymphocytes despite low expression of major histocompatibility complex class I molecules.

Authors:  Ralf Dressel; Kaomei Guan; Jessica Nolte; Leslie Elsner; Sebastian Monecke; Karim Nayernia; Gerd Hasenfuss; Wolfgang Engel
Journal:  Biol Direct       Date:  2009-08-28       Impact factor: 4.540

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.